About Nichepharm
Nichepharm is a company based in Gurugram (India) founded in 2019. The company has 199 employees as of December 10, 2024. Nichepharm has completed 1 acquisition, including Recipharm. Nichepharm offers products and services including Liquid Ampoules, Liquid Vials, Dry Powder Injection, Lyophilized Injection, and Pre-Filled Syringes. Nichepharm operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Gurugram, India
- Employees 199 as on 10 Dec, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nichepharm Lifesciences Private Limited
- Date of Incorporation 16 Oct, 2019
- Jurisdiction Gurgaon, Haryana, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nichepharm
Nichepharm offers a comprehensive portfolio of products and services, including Liquid Ampoules, Liquid Vials, Dry Powder Injection, Lyophilized Injection, and Pre-Filled Syringes.
Manufactures liquid ampoules for pharmaceutical formulations.
Produces liquid vials for various therapeutic applications.
Offers dry powder injections for antibiotics and other uses.
Provides lyophilized injections for stable drug delivery.
Manufactures pre-filled syringes for convenient administration.
Funding Insights of Nichepharm
Investors in Nichepharm
Nichepharm has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Recipharm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical development and manufacturing services are offered contractually.
|
Locked | Locked | Locked |
Investor details for Nichepharm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nichepharm
Nichepharm has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Recipharm.
Investment portfolio details for Nichepharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmaceutical development and manufacturing services are offered contractually.
|
Locked | Locked | 1995 | Locked |
Complete acquisition details for Nichepharm
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Nichepharm
Detailed financials for Nichepharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nichepharm Comparisons
Peer comparison for Nichepharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nichepharm
Nichepharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Nichepharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nichepharm
Complete news archive for Nichepharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nichepharm
Nichepharm was founded in 2019 and raised its 1st funding round 5 years after it was founded.
Nichepharm is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
As of Dec 10, 2024, the latest employee count at Nichepharm is 199.
Annual revenue of Nichepharm is $25.38M as on Mar 31, 2024.
Nichepharm Lifesciences was founded in 2019 in Gurugram, India, as a contract development and manufacturing organization within the pharmaceutical sector. Injectable products, including liquid ampoules, vials, cartridges, and syringes, are produced in specialized units. Global clients are supported through these operations, which build on over 20 years of industry experience focused on quality standards.
Nichepharm's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Nichepharm offers Liquid Ampoules, Liquid Vials, Dry Powder Injection, Lyophilized Injection, and Pre-Filled Syringes.
Nichepharm has made 1 acquisition, including Recipharm.
Nichepharm has 1 investor. Key investors include Recipharm.